VivoSim Labs, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31)
VivoSim Labs, Inc. (VIVS) had Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) of 31.59 million shares as of 2012-03-31, per its 10-Q filed 2012-05-15.
Discontinued › Notes
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicAndDiluted · last filed 2012-05-15
- 2012-03-31: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 31.59M shares.
- 2011-03-31: Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) 14.88M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) |
|---|---|
| 2012-03-31 | 31.59M shares 10-Q · filed 2012-05-15 |
| 2011-03-31 | 14.88M shares 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |